Clinigen and Theravance Announce Exclusive Commercialization Agreement in the EU for VIBATIV(R) (telavancin)

[at noodls] – BURTON-ON-TRENT, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA — (Marketwire) — 03/11/13 — Clinigen Group plc (LSE: CLIN) (AIM: CLIN) and Theravance, Inc. (NASDAQ: THRX) today announced that they have … more

View todays social media effects on THRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Theravance is hiring next, click here to view